Lidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution — RxCUI 1010878
RxNorm drug concept · Semantic clinical drug
RxCUI 1010878
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
16 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1010878
Official nameLidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine hydrochloride 4 % Oromucosal Solution; lidocaine HCl 4 % Mucous Membrane Topical Solution; lidocaine hydrochloride 4 % Mucous Membrane Topical Solution
FDA products mapped16
Package NDCs mapped16
Reported Medicaid activity (SDUD)5,839 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
- What is this patch actually for — why did my doctor prescribe it?
- You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
- How long do I wear the patch, and can I wear more than one?
🕸️ Concept Web — How Lidocaine hydrochloride 40 MG/ML Mucous Membrane... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution
RxCUI 1010878 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN -
Lidocaine hydrochloride
142440PIN
-
Lidocaine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xylocaine
202398BN
-
Xylocaine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine Mucous Membrane Topical Solution
375137SCDF -
Lidocaine hydrochloride Mucous Membrane Topical Solution
2645381SCDFP -
Lidocaine Mucosal Product
1164660SCDG -
Lidocaine hydrochloride Mucosal Product
2659393SCDGP -
Lidocaine Mucous Membrane Topical Solution [Xylocaine]
543931SBDF -
Lidocaine hydrochloride Mucous Membrane Topical Solution [Xylocaine]
2656307SBDFP -
Xylocaine Mucosal Product
1186621SBDG -
Mucous Membrane Topical Solution
316956DF - +1 more in this family
-
Lidocaine Mucous Membrane Topical Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine hydrochloride 40 MG/ML
1010843SCDC -
Lidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution [Xylocaine]
1246113SBD -
Lidocaine hydrochloride 40 MG/ML [Xylocaine]
1010845SBDC
-
Lidocaine hydrochloride 40 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine hydrochloride 40 MG/ML
SCDC · 1010843 -
Lidocaine Mucous Membrane Topical Solution
SCDF · 375137 -
Lidocaine hydrochloride Mucous Membrane Topical Solution
SCDFP · 2645381 -
Lidocaine Mucosal Product
SCDG · 1164660 -
Lidocaine hydrochloride Mucosal Product
SCDGP · 2659393
Brand-Name Concepts
-
Lidocaine hydrochloride 40 MG/ML Mucous Membrane Topical Solution [Xylocaine]
SBD · 1246113 -
Lidocaine hydrochloride 40 MG/ML [Xylocaine]
SBDC · 1010845 -
Lidocaine Mucous Membrane Topical Solution [Xylocaine]
SBDF · 543931 -
Lidocaine hydrochloride Mucous Membrane Topical Solution [Xylocaine]
SBDFP · 2656307 -
Xylocaine Mucosal Product
SBDG · 1186621 -
Xylocaine
BN · 202398
📦 FDA Products & Package NDCs
16 products · 16 package NDCs
16 package NDCs map to RxCUI 1010878 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-3505-47 | 50 mL in 1 BOTTLE (0054-3505-47) | Lidocaine Hydrochloride | Hikma Pharmaceuticals USA Inc. | 1985-04-03 |
| 00116-4025-50 | 1 BOTTLE, GLASS in 1 CARTON (0116-4025-50) / 50 mL in 1 BOT... | LIDOCAINE HYDROCHLORIDE | Xttrium Laboratories, Inc. | 2025-03-31 |
| 00121-0972-51 | 1 BOTTLE, GLASS in 1 CARTON (0121-0972-51) / 50 mL in 1 BOT... | Lidocaine Hydrochloride | PAI Holdings, LLC dba PAI Pharma | 2023-07-31 |
| 00527-6004-80 | 1 BOTTLE in 1 CARTON (0527-6004-80) / 50 mL in 1 BOTTLE | Lidocaine Hydrochloride | Lannett Company, Inc. | 2007-02-27 |
| 10135-0736-51 | 1 BOTTLE in 1 CARTON (10135-736-51) / 50 mL in 1 BOTTLE | Lidocaine Hydrochloride | Marlex Pharmaceuticals, Inc. | 2022-06-01 |
| 51407-0825-50 | 50 mL in 1 BOTTLE (51407-825-50) | Lidocaine Hydrochloride | Golden State Medical Supply, Inc. | 2023-08-08 |
| 51662-1553-03 | 25 POUCH in 1 CASE (51662-1553-3) / 1 VIAL in 1 POUCH (5166... | LIDOCAINE HCl | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-14 |
| 51672-1411-03 | 1 BOTTLE in 1 CARTON (51672-1411-3) / 50 mL in 1 BOTTLE | Lidocaine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 2023-12-08 |
| 63629-2096-01 | 50 mL in 1 BOTTLE (63629-2096-1) | Lidocaine Hydrochloride | Bryant Ranch Prepack | 2021-02-11 |
| 63739-0997-64 | 1 BOTTLE in 1 CARTON (63739-997-64) / 50 mL in 1 BOTTLE | Lidocaine Hydrochloride | McKesson Corporation dba SKY Packaging | 2024-06-27 |
| 70954-0518-10 | 1 BOTTLE in 1 CARTON (70954-518-10) / 50 mL in 1 BOTTLE | Lidocaine Hydrochloride | Novitium Pharma LLC | 2022-03-23 |
| 72162-1098-02 | 1 BOTTLE in 1 CARTON (72162-1098-2) / 50 mL in 1 BOTTLE | Lidocaine Hydrochloride | Bryant Ranch Prepack | 2023-09-26 |
| 72162-2620-02 | 1 BOTTLE, GLASS in 1 CARTON (72162-2620-2) / 50 mL in 1 BOT... | LIDOCAINE HYDROCHLORIDE | Bryant Ranch Prepack | 2026-04-20 |
| 72162-2627-02 | 1 BOTTLE in 1 CARTON (72162-2627-2) / 50 mL in 1 BOTTLE | Lidocaine Hydrochloride | Bryant Ranch Prepack | 2026-04-23 |
| 76329-6300-05 | 25 VIAL in 1 CARTON (76329-6300-5) / 4 mL in 1 VIAL | Lidocaine Hydrochloride | International Medication Systems, Limited | 2012-06-19 |
| 83148-0043-50 | 1 BOTTLE in 1 CARTON (83148-043-50) / 50 mL in 1 BOTTLE | Lidocaine Hydrochloride | The J. Molner Company LLC | 2024-11-01 |
Observed labelers:
Bryant Ranch Prepack (4) ·
Golden State Medical Supply, Inc. (1) ·
HF Acquisition Co LLC, DBA HealthFirst (1) ·
Hikma Pharmaceuticals USA Inc. (1) ·
International Medication Systems, Limited (1) ·
Lannett Company, Inc. (1)
· +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.